HHS pays $122.7M for manufacture of anthrax vaccine
Emergency Management Alert, May 10, 2005
The federal Department of Health and Human Services (HHS) recently awarded a $122.7 million contract to a Michigan company to produce five million doses of an anthrax vaccine.
BioPort Corporation, which is based in Lansing, will manufacture Anthrax Vaccine Adsorbed for the nation's Strategic National Stockpile. It will be available in the event of a bioterrorism anthrax attack.
The supply of the anthrax vaccine is paid for under Project BioShield, a federal program intended to accelerate the development, purchase, and availability of medical weapons against biological, chemical, radiological, and nuclear threats.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- Q&A: Coding for dry skin due to cold weather
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Catch up on what's new with injections and infusions
- Privacy, security concerns high in HIEs
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- Q&A: Coding for sepsis when other conditions are present
- Are your workforce members texting PHI?
- HIPAA Q&A: TPO disclosures to a business associate
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Searched
